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Abstract Rationale: Functional imaging studies have
revealed overactivity of the hippocampus in schizo-
phrenic patients. Neuropathological data indicate that
hyperactivity of excitatory hippocampal afferents and
decreased hippocampal GABA transmission contribute
to this overactivity. In rats, excitation of the ventral hip-
pocampus, e.g. by NMDA, results in hyperactivity and
disruption of sensorimotor gating measured as prepulse
inhibition (PPI) of the acoustic startle response, behav-
ioral effects related to psychotic symptoms in humans.
Objective: The present study examined whether disinhi-
bition of the ventral hippocampus by the GABAA antag-
onist picrotoxin would result in similar psychosis-related
behavioral disturbances (hyperactivity, decreased PPI) as
NMDA stimulation. Methods and results: Wistar rats re-
ceived bilateral infusions of subconvulsive doses of pi-
crotoxin (100 or 150 ng/0.5 µl per side) into the ventral
hippocampus and were then immediately tested for open
field locomotor activity or startle reactivity and PPI. On-
ly the higher dose induced hyperactivity and decreased
PPI. Both doses decreased acoustic startle reactivity to a
similar extent. The decreased PPI appeared not to result
from decreased startle reactivity, but was associated with
a diminished potency of the prepulses to inhibit the star-
tle reaction to the startle pulse, indicating a sensorimotor
gating deficit. All effects were temporary, i.e. disap-
peared when the rats were tested 24 h after infusion.
Conclusions: Decreased GABAergic inhibition in the
ventral hippocampus of rats yielded psychosis-related
behavioral effects, very similar to those induced by
NMDA stimulation. Thus, a concurrence of decreased
GABAergic inhibition and increased afferent excitation
in the hippocampus of schizophrenic patients might con-
tribute to psychotic symptoms.
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Introduction
Animal studies concerned with hippocampal functioning
receive particular interest, as aberrant hippocampal func-
tioning in humans has been implicated in neuropsychiat-
ric disorders such as anxiety and schizophrenia (Gray et
al. 1991; Gray 1995; Benes 2000; Grace 2000). Func-
tional imaging studies indicate that hippocampal activity
is increased in schizophrenic patients and hippocampal
overactivity has been associated with the experience of
positive symptoms (Friston et al. 1992; Liddle et al.
1992; Silbersweig et al. 1995; Kawasaki et al. 1996;
Heckers et al. 1998; Dierks et al. 1999; Frith 1999; 
Shergill et al. 2000).
In rats, overactivity of the ventral hippocampus, in-
duced, for example, by infusion of NMDA to stimulate
the NMDA-type receptor of the excitatory transmitter
glutamate, generates behavioral effects which might be
related to some positive symptoms occurring in schizo-
phrenia. Locomotor activity in the open field is in-
creased following NMDA stimulation of the ventral 
hippocampus (Yang and Mogenson 1987; Wu and
Brudzynski 1995; Brudzynski and Gibson 1997; 
Bardgett and Henry 1999; Legault and Wise 1999; Bast
et al. 2001b). Aberrant locomotor activity in the rat
might be homologous to some changes in human cogni-
tive function observed in acute schizophrenia (Gray et
al. 1999). Furthermore, prepulse inhibition (PPI) of the
acoustic startle response is disrupted following NMDA
stimulation of the ventral hippocampus (Wan et al.
1996; Klarner et al. 1998; Koch et al. 1999; Zhang et al.
1999; Bast et al. 2001b). PPI is the reduction of the star-
tle response to an intense acoustic pulse by an immedi-
ately preceding weaker stimulus, or prepulse. It may re-
flect sensorimotor gating mechanisms induced by the
prepulse and preventing its processing from being inter-
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rupted (Graham 1975; Norris and Blumenthal 1996).
Deficient sensorimotor gating, as reflected by disruption
of PPI, has been found in several neuropsychiatric dis-
orders, especially in schizophrenia (Braff et al. 1978;
Grillon et al. 1992; Perry and Braff 1994; Karper et al.
1996; Braff et al. 1999; Perry et al. 1999; Kumari et al.
2000; Parwani et al. 2000; Weike et al. 2000). Although
there is little doubt about the existence of a PPI deficit
in schizophrenia, its contribution to schizophrenic
symptoms is not yet clear. However, deficient PPI has
been postulated to contribute to sensory overload and
cognitive fragmentation, which in turn result in psychot-
ic symptoms, and correlations between decreased PPI
and the severity of pychotic symptoms, in particular
positive symptoms, have been reported by some studies
(Perry and Braff 1994; Karper et al. 1996; Braff et al.
1999; Perry et al. 1999; Weike et al. 2000). Disrupted
PPI in rats is used to model sensorimotor gating deficits
observed in schizophrenia (Swerdlow et al. 1994,
2000a).
Overactivity of a brain structure can come about by
increased excitatory neurotransmission and by disinhibi-
tion, i.e. a decrease of inhibitory transmission. In the hip-
pocampus, inhibition is mainly mediated by actions of
GABA, which is released by hippocampal interneurons,
at the GABAA receptor, a ligand-operated Cl–-channel(Buhl et al. 1994). Neuropathological studies indicate
that increased excitatory transmission via hippocampal
afferents in concert with a local decrease of GABAergic
inhibition (possibly due to a loss of hippocampal GABA
interneurons) might yield the hippocampal overactivity
revealed by functional imaging studies in schizophrenic
patients (for review see: Benes 2000). Moreover, dys-
functions of GABA transmission have been implicated
in the processes leading to psychosis (Keverne 1999;
Lacroix et al. 2000) and psychotic symptoms in schizo-
phrenia have been found to be correlated with reduced
GABAergic inhibition in the medial temporal region
(Busatto et al. 1997). Thus, decreased inhibitory GABA
transmission in the hippocampus of schizophrenic pa-
tients might contribute to psychotic symptoms in schizo-
phrenia.
In the present study, we tested in Wistar rats if the
disinhibition of the ventral hippocampus by local mi-
croinfusion of the GABAA receptor antagonist picro-
toxin would yield effects on PPI and locomotor activity
in the open field that are similar to those resulting from
stimulation of the ventral hippocampus by NMDA
(Zhang et al. 1999; Bast et al. 2001b). In a recent study,
bilateral infusion of 5 or 10 ng picrotoxin/side into the
ventral hippocampus of Sprague-Dawley rats did not
significantly affect startle amplitude or PPI (Japha and
Koch 1999). The authors reported difficulties in testing
higher doses because of convulsions occurring at high-
er doses. In our own pilot studies, doses up to 50 ng pi-
crotoxin/side did not reveal any considerable behavior-
al effect or convulsive properties. Therefore, we used
doses of 100 or 150 ng picrotoxin/side in the present
study.
Materials and methods
Animals
A total of 50 male adult Wistar rats (Zur:Wist[HanIbm]; Research
Unit Schwerzenbach, Schwerzenbach, Switzerland), weighing
about 250 g at the time of surgery, were used in this study. The an-
imals were housed in groups of four per cage under a reversed
light-dark cycle (lights on: 1900–0700 hours) in a temperature
(21±1°C) and humidity (55±5%) controlled room and were al-
lowed free access to food and water. All rats received bilateral im-
plantation of infusion guide cannulae aiming at the ventral hippo-
campus. After surgery, they were individually caged. Beginning 
3 days before surgery and throughout the studies, all rats were
handled daily. Behavioral testing was carried out in the dark phase
of the cycle. All experiments were conducted in accordance with
Swiss regulations for animal experimentation.
Implantation of guide cannulae for intracerebral infusion
Rats were anaesthetized with 1 ml of Nembutal (sodium pentobar-
bital, 50 mg/ml; Abbott Labs, North Chicago, Ill., USA) per kg
body weight and their head was placed in a Kopf stereotaxic
frame. After application of a local anaesthetic (lidocaine), the
scalp was incised to expose the skull. Bregma and lambda were
aligned in the same horizontal plane. A small hole (1.5 mm diame-
ter) was drilled on each side of the skull to reveal the dura cover-
ing the cortex overlying the ventral hippocampus. Three small
stainless steel screws were screwed into the skull and two guide
cannulae (9 mm, 26 gauge; stainless steel) were implanted bilater-
ally into the brain through boreholes in the skull. The tips of the
guide cannulae were aiming above the ventral hippocampus
(5.2 mm posterior and ±5 mm lateral to bregma, and 5 mm ventral
to dura). Guide cannulae were fixed by dental cement for which
the three screws served as anchors to the skull. Stainless steel sty-
lets (34 gauge) extending 0.5 mm beyond the tips of the guide
cannulae were placed inside the guide cannulae to prevent occlu-
sion. After surgery, rats were allowed to recover for 5 days during
which the experimenters gave the rats daily health checks and
gentle handling, and replaced missing stylets.
Intracerebral microinfusion
The rats were manually restrained, the stylets were removed from
the guide cannulae, and infusion cannulae (34 gauge), connected
to 10-µl Hamilton microsyringes mounted on a microinfusion
pump (KD scientific or WPI sp200i), were inserted into the guide
cannulae. The tips of the infusion cannulae protruded into the ven-
tral hippocampus 1.5 mm beyond the tips of the guide cannulae,
thus aiming at a final dorsoventral coordinate of 6.5 mm below the
dura. The rats were bilaterally infused with 100 or 150 ng picro-
toxin in 0.5 µl vehicle or 0.5 µl vehicle only. The infusion speed
was 0.5 µl/min. After infusion, the infusion cannulae were left in
the brain for 60 s to allow for absorption of the infusion bolus by
the brain tissue and then replaced by the stylets. Rats were then
immediately subjected to behavioral testing.
Drug preparation
The picrotoxin solutions were prepared freshly on the day of ex-
periment. Picrotoxin (C30H34O13; Fluka, Switzerland) was dis-
solved in 0.9% saline as vehicle to obtain concentrations of 200 or
300 µg/ml for infusion of 100 or 150 ng (0.17 or 0.25 nmol)/
0.5 µl. The final pH was 6–7.
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Apparatus and procedures for behavioral testing
Open field locomotor activity
Locomotor activity was measured in four closed square arenas
(76.5 cm×76.5 cm×49 cm) made of dark gray plastic and placed in
a dimly illuminated (20±0.5 Lux provided by two halogen lights)
room. Behavior in the arenas was recorded by a video camera sus-
pended from the ceiling and relayed to a monitor and a video
tracking, motion analysis and behavior recognition system (Etho-
Vision, Noldus, Wageningen, The Netherlands).
Startle and prepulse inhibition
The testing was conducted in four ventilated startle chambers (SR-
LAB, San Diego Instruments, San Diego, Calif., USA), containing
a transparent Plexiglas tube (diameter 8.2 cm, length 20 cm)
mounted on a Plexiglas frame. Noise bursts were presented via a
speaker mounted 24 cm above the tube. Motion inside the tube
was detected by a piezoelectric accelerometer below the frame.
The amplitude of the whole body startle to an acoustic pulse was
defined as the average of 100 1-ms accelerometer readings collect-
ed from pulse onset. A background noise level of 68 dB(A) was
maintained throughout the test sessions. A test session started with
5 min of acclimatization, after which four startle pulses [30 ms,
120 dB(A)] were presented. These four initial startle pulses served
to achieve a relatively stable level of startle reactivity for the re-
mainder of the test session, as most rapid habituation of the startle
reflex occurs within the first few startle pulse presentations (Koch
1999). After the four initial startle pulses, six blocks of 11 trials
were presented to measure PPI. The 11 trials of each block includ-
ed: two pulse alone trials, one prepulse followed by pulse as well
as one prepulse alone trial for each of four prepulse intensities,
and one no stimulus trial. The prepulses were broad band bursts of
20 ms duration and an intensity of 72, 76, 80, or 84 dB(A). The
time span between prepulse offset and pulse onset was 80 ms. The
different trial types were presented pseudorandomly with an inter-
trial interval of 10–20 s (average 15 s). Altogether, a complete test
session lasted about 23 min.
Experimental design
The experimental groups comprised three infusion groups to re-
ceive bilateral infusion of vehicle (VEH), 100 ng picrotoxin/side
(PTX100) or 150 ng picrotoxin/side (PTX150) into the ventral
hippocampus. The effects of picrotoxin infusion into the ventral
hippocampus were tested on (1) open field locomotor activity or
(2) startle response and PPI. All 50 animals used in the present
study had received one vehicle infusion or infusion of 50 ng picro-
toxin/0.5 µl per side throughout previous pilot experiments. In ad-
dition, 27 rats were used in the PPI experiment before being sub-
jected to the open field experiment of this study. Those which re-
ceived vehicle infusion during the PPI experiment received picro-
toxin (150 ng/side) infusion during the open field experiment, and
vice versa. Between the different infusions and experiments there
was always a time span of at least seven days. Since both the PPI
and the open field experiment included one day of testing before
the day of infusion it could be verified that the rats with a different
“experimental and infusion history” did not differ in the measure-
ments relevant to the present study. In addition, both the PPI and
the open field experiment included 1 test day following the day of
infusion to check for possible long-term effects of the picrotoxin
infusion.
Open field experiment
The open field experiment was run on 3 successive days and in-
cluded two groups: VEH (n=17) and PTX150 (n=14). The picro-
toxin dose was based on pilot studies yielding no hint of a loco-
motor effect of infusions of 10–50 ng picrotoxin/side into the ven-
tral hippocampus. A PTX100 group was not included because
open field testing of the first few animals of the PTX150 group
suggested that even the locomotor effects of the higher picrotoxin
dose were moderate. On day 1, each rat was placed in the center of
one arena and its locomotor activity was recorded for 30 min. On
day 2 (day of infusion), each rat was placed in the center of one of
the arenas and its locomotor activity in the open field was moni-
tored for 30 min. Then, the rats were returned to their home cages
and moved to an infusion room to receive their infusions. After
the infusion, all rats were replaced into the arena for an additional
60 min to check for the acute effect of picrotoxin infusion into the
ventral hippocampus on locomotor activity (between-subjects de-
sign). On day 3 (day after infusion), each rat was placed in the
center of one of the arenas and its locomotor activity was moni-
tored for 30 min.
Prepulse inhibition experiment
The PPI experiment was conducted on 3 successive days and in-
cluded three groups: VEH (n=16), PTX100 (n=7), and PTX150
(n=18). On day 1, basal startle and PPI were tested without infu-
sion for all rats. On day 2 (day of infusion), startle and PPI were
measured immediately following infusion to compare the acute ef-
fect of picrotoxin and vehicle infusion (between-subjects design).
On day 3 (day after infusion), all rats were tested for startle and
PPI without an infusion.
Histology
After completion of the behavioral experiments, rats were deeply
anesthetized with 2.5 ml/kg Nembutal (sodium pentobarbital,
50 mg/ml, IP) and transcardially perfused with 0.9% saline solu-
tion to rinse out the blood, followed by 250 ml of 4% formalin
(4°C) to fix the brain tissue. The brains were extracted from the
skull, post-fixed in 4% formalin solution, and subsequently cut in-
to 40-µm coronal sections on a freezing microtome. For the verifi-
cation of the infusion sites, every fifth section through the ventral
hippocampus was mounted on gelatine-treated slides and stained
with cresyl violet. After staining, the sections were dehydrated and
coverslipped. Subsequently, they were examined by light micros-
copy to verify that the tips of the infusion cannulae were placed in
the ventral hippocampus and to draw their approximate locations
onto plates taken from the atlas of Paxinos and Watson (1998).
Data analysis
All statistical analyses were performed with the StatView software
system (Abacus Concepts, Inc., Berkeley, Calif., USA, 1992) us-
ing analysis of variance (ANOVA). Data are presented as means.
In the text and in bar plots, the variability is indicated by the stan-
dard error of the mean (SEM). In line plots, for the sake of clarity,
twice the standard error (SE) derived from the appropriate mean
square yielded by the ANOVA was used to indicate variability.
Fisher’s protected least significant difference test was used for
post hoc comparisons following a significant main effect revealed
by ANOVA. In order to interpret significant interactions indicated
by ANOVA, significant differences between the mean values of
interest were estimated by using 2 SE derived from the appropri-
ate mean square of the ANOVA (see Winer 1971, p. 199), since
the StatView software only conducts post hoc comparisons rele-
vant to main effects. Significant differences were accepted at
P<0.05.
Open field experiment
The total distance the rat moved in cm throughout the complete
arena was calculated for each 10-min block of testing. Groups
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were taken as between-subjects factor and the 10-min blocks as
repeated measures.
Prepulse inhibition experiment
The percentage PPI (%PPI) induced by each prepulse intensity
was calculated as: [100–(100×startle amplitude on prepulse fol-
lowed by pulse trial)/(startle amplitude on pulse alone trial)] from
the data taken during the six test blocks to measure PPI. For statis-
tical analysis of the startle and %PPI data, groups were used as be-
tween-subjects factor and the 16 pulse alone trials (startle data) or
four prepulse intensities (%PPI data) were taken as repeated mea-
sures. On the day of infusion, decreased %PPI occurred with a
concomitant decrease of the average startle amplitude in the 16
pulse alone trials. As recently discussed extensively by Swerdlow
et al. (2000a), decreased %PPI with concomitant changes of startle
amplitude in pulse alone trials cannot unequivocally be ascribed to
deficient induction of sensorimotor gating processes by the pre-
pulses. In order to assess if the prepulses’ potency to reduce the
startle response was affected, PPI was also assessed by comparing
the startle magnitude in the pulse alone and the prepulse followed
by pulse trials of the six test blocks. For this purpose, startle data
of the pulse alone trials and the four different prepulse followed
by pulse (one for each prepulse intensity) trials were subjected to
ANOVA using the five trial types as repeated measures.
Results
Location of infusion sites
In all 50 cannulated rats, the tips of the infusion cannulae
were located within or around the border of the ventral
hippocampus (Fig. 1). Damage resulting from the im-
plantation of the guide cannulae was restricted to the ar-
ea immediately surrounding the tracks of guide and infu-
sion cannulae.
Picrotoxin infusions into the ventral hippocampus 
did not induce convulsions
Picrotoxin infusions (100 and 150 ng/side) into the ven-
tral hippocampus did not induce convulsions. Also,
tremor, sniffing, or whisker shaking, which sometimes
occur following NMDA infusions (Bast et al. 2001b),
were not observed. Some rats which received 150 ng pi-
crotoxin/side exhibited shaking of their hind body during
a period of some minutes beginning briefly after infu-
sion.
Picrotoxin infusion into the ventral hippocampus 
increased locomotor activity
On day 1 of the open field experiment (day before infu-
sion), PTX150 and VEH groups did not differ in the dis-
tance moved in the open field [F(1,29)=0.1, P>0.7; data
not shown]. ANOVA revealed only a highly significant
effect of 10-min block [F(2,58)=133.8, P<0.0001], re-
flecting habituation to the open field. On day 2 (day of
infusion), both groups did not differ throughout the
30 min preceding the infusion [F(1,29)=2.8, P>0.1;
Fig. 2, left]. For these 30 min, ANOVA yielded only a
highly significant effect of 10-min block [F(2,58)=79.0,
P<0.0001], reflecting habituation. Following infusion,
the PTX150 group exhibited increased activity as com-
pared to the VEH group (Fig. 2, middle). ANOVA of the
total distance moved yielded a significant effect of group
[F(1,29)=4.5, P<0.05], a highly significant effect of 
10-min block [F(5,145)=40.2, P<0.0001], as well as a
highly significant group×10-min block interaction
[F(5,145)=6.9, P<0.0001]. The latter reflected that the
locomotor activity in the PTX150 group was significant-
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Fig. 1A, B Infusion sites in the ventral hippocampus. A Photomi-
crograph of a coronal brain section with the tracks of the guide
cannulae and beneath them the infusion sites visible in both hemi-
spheres. B Approximate location of the tips of the infusion cannu-
lae depicted on plates of coronal sections through the rat brain
(Paxinos and Watson 1998). Values on the right represent distance
from bregma. CA1, CA2, and CA3 CA1, CA2, and CA3 field of
the hippocampus, DG dentate gyrus, Ent entorhinal cortex, S sub-
iculum
ly increased relative to the VEH group only during the
first three 10-min blocks following infusion, whereas
both groups exhibited similar locomotor activity
throughout the rest of the session (based on comparisons
using the SE derived from ANOVA). Thus, locomotor
activity in the PTX150 group was normalized at about
40 min after infusion. On day 3 (day after infusion), both
groups exhibited similar activity levels [F(1,29)=0.2,
P>0.6] and ANOVA revealed only a highly significant
effect of 10-min block [F(2,58)=118.4, P<0.0001], re-
flecting habituation (Fig. 2, right).
Picrotoxin infusion into the ventral hippocampus 
decreased the startle amplitude and caused a 
dose-dependent disruption of prepulse inhibition
The startle reactivity measured in the pulse alone trials
was decreased by infusion of both 100 and 150 ng pi-
crotoxin/side into the ventral hippocampus (Fig. 3A).
ANOVA yielded a significant effect of group on the av-
erage startle amplitude during the 16 pulse alone trials
on the day of infusion [day 2; F(2,38)=8.4, P<0.002],
but not on the day before infusion [day 1; F(2,38)=0.8,
P>0.4] or the day after infusion [day 3; F(2,38)=1.1,
P>0.3]. Post hoc comparisons revealed that on the day of
infusion the average startle amplitude (mean±SEM) was
decreased in the PTX100 (660±128; P=0.053) and
PTX150 (460±72; P<0.0002) groups, which did not dif-
fer (P>0.25), as compared to the VEH group
(1020±130). Short-term habituation of the startle re-
sponse (Koch 1999) was not affected by picrotoxin infu-
sion into the ventral hippocampus. This was reflected by
a highly significant effect of pulse alone trial (all
P<0.0001) occurring without a group×pulse alone trial
interaction (all P>0.1) on each of the 3 days.
Infusion of 150, but not 100 ng picrotoxin/side de-
creased the %PPI (Fig. 3B). ANOVA yielded a signifi-
cant effect of group on the %PPI on the day of infusion
[day 2; F(2,38)=7.0, P<0.005], but not on the day before
infusion [day 1; F(2,38)=0.6, P>0.5] or the day after in-
fusion [day 3; F(2,38)=1.4, P>0.25]. Post hoc compari-
sons revealed that on the day of infusion the average
%PPI (mean±SEM) over all four prepulse intensities was
decreased in the PTX150 (18.2±4.7) as compared to both
the PTX100 (45.4±10.4; P<0.01) and the VEH group
(44.1±5.8; P<0.002), which did not differ (P>0.9). A
gradual increase of the %PPI with an increase in pre-
pulse intensity (Koch 1999) was evident in all groups on
each of the three days. This was reflected by a highly
significant effect of prepulse intensity (all P<0.0001) oc-
curring without a group×prepulse intensity interaction
(all P>0.1) on each day.
A comparison of the startle amplitude throughout the
pulse alone trials and the prepulse followed by pulse tri-
als of the six blocks to measure PPI revealed that the
prepulse potency to decrease the startle amplitude to the
pulse was markedly diminished in the PTX150 group,
whereas it was intact for all prepulse intensities in the
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Fig. 2 Locomotor activity in the open field after picrotoxin infu-
sion into the ventral hippocampus. On the day of infusion, the
rats’ locomotor activity in the open field was recorded for 30 min
before infusion of vehicle (VEH; n=17) or 150 ng picrotoxin/side
(PTX150; n=14) into the ventral hippocampus (left). Following in-
fusion, activity was further recorded for 60 min (middle). The day
after infusion (right), the rats’ locomotor activity was recorded for
30 min. Locomotor activity is represented as the distance moved
(mean in cm) during consecutive 10-min blocks. The bar repre-
sents 2 SE derived from the ANOVA. Asterisks denote a differ-
ence of more than 2 SE between the two groups
Fig. 3A–C Startle reactivity and prepulse inhibition after picro-
toxin infusion into the ventral hippocampus. Rats were bilaterally
infused with vehicle (VEH; n=16), 100 ng picrotoxin/side
(PTX100; n=7) or 150 ng picrotoxin/side (PTX150; n=18) into the
ventral hippocampus on day 2. All groups were tested for PPI
without infusion 1 day before (day 1) and one day after (day 3) the
infusion day (day 2). A Average startle magnitude (mean+SEM)
during the 16 pulse alone trials for all 3 days. Differences to the
VEH group indicated by post hoc comparisons are denoted
(*P<0.0002; #P=0.053). B Mean percentage of prepulse inhibition
averaged across all prepulse intensities for all three days. The bars
represent 2 SE derived from ANOVA. C Mean startle amplitude
throughout the pulse alone (P) and the prepulse followed by pulse
(PP+P) trials of the six test blocks to measure PPI on the day of
infusion. The different prepulse intensities in dB(A) are indicated.
The bar represents 2 SE derived from ANOVA. Startle amplitudes
in the prepulse followed by pulse trials (PP+P) which differed by
more than 2 SE from that during the pulse alone trials (P) of the
same group are denoted by asterisks
PTX 100 and VEH groups (Fig. 3C). ANOVA of the
startle data measured throughout the six blocks to test
PPI on the day of infusion yielded a significant effect of
group [F(2,38)=3.8, P<0.05], reflecting the decreased
startle reactivity in the PTX100 and PTX150 as com-
pared to the VEH group, a highly significant effect of tri-
al type [F(4,152)=31.5, P<0.0001], and a highly signifi-
cant group×trial type interaction [F(8,152)=6.7,
P<0.0001]. The interaction reflected that the PTX100
and the VEH group exhibited a similar gradual decrease
in startle reaction to the pulse when the pulse was pre-
ceded by increasing prepulses, whereas this effect of the
prepulses was markedly decreased in the PTX150 group.
In the VEH and the PTX100 group, the startle amplitude
was significantly decreased in all prepulse followed by
pulse trials as compared to the pulse alone trials, where-
as in the PTX150 group only the highest, but not the
three lower prepulse intensities had the potency to sig-
nificantly reduce the startle reaction to the pulse (based
on comparisons using the SE derived from the ANOVA).
Moreover, in the pulse alone trials, startle amplitude
(mean±SEM) appeared to be higher in the PTX100
(520±130) than in the PTX150 (400±71) group. This re-
lation seemed to be reversed in the prepulse followed by
pulse trials. When the pulses were preceded by prepulses
of 76, 80, and 84 dB(A), the startle amplitude to the
pulses appeared to be higher in the PTX150 (330±69,
330±63, 240±42) than in the PTX100 (250±48, 220±48,
170±33) group. Thus, the decreased %PPI in the
PTX150 group was not just due to a decreased startle re-
activity in the pulse alone trials but associated with a di-
minished potency of the prepulses to reduce the startle
amplitude in the prepulse followed by pulse trials.
Discussion
Disinhibition of the ventral hippocampus by local micro-
infusion of the GABAA antagonist picrotoxin induced
hyperactivity in the open field, decreased startle reactivi-
ty, and disrupted PPI. All effects were evident only
throughout the test sessions immediately following infu-
sion but not 24 h later, indicating that they were due to
temporary alterations of neuronal activity in the ventral
hippocampus. Infusions of 100 or 150 ng picrotoxin/side
into the ventral hippocampus of our Wistar rats did not
induce convulsions. In contrast, Japha and Koch (1999)
reported doses above 10 ng picrotoxin/side to be convul-
sive when infused into the ventral hippocampus of
Sprague-Dawley rats. The different observations might
be related to strain differences. In agreement with our
observation, however, doses higher than 300 ng/side had
to be applied to the amygdala to induce the slightest sei-
zure grade in Wistar rats in an animal model of temporal
lobe epilepsy (Turski et al. 1985).
Hyperactivity following picrotoxin infusion into 
the ventral hippocampus
The hyperactivity in the open field following disinhibi-
tion of the ventral hippocampus by picrotoxin adds to
the evidence that activity of the ventral hippocampus
drives locomotor activity. Thus, infusions of stimulato-
ry neuroactive substances into the ventral hippocampus
stimulate locomotor activity (Yang and Mogenson
1987; Wu and Brudzynski 1995; Brudzynski and 
Gibson 1997; Brenner and Bardgett 1998; Bardgett and
Henry 1999; Legault and Wise 1999; Bast et al. 2001b),
whereas increased inhibition of the ventral hippocam-
pus by the GABAA receptor agonist muscimol or com-
plete inactivation by the sodium channel blocker tetro-
dotoxin result in hypoactivity in the open field (Bast et
al. 2001a). In view of the data from infusion studies,
hyperactivity observed under certain circumstances af-
ter ventral hippocampal lesions (Nadel 1968; Lipska et
al. 1992; Richmond et al. 1999) does not appear to re-
flect a suppressive influence of the ventral hippo-
campus on locomotor activity. This hyperactivity 
might rather be related to lesion-induced damage in ex-
tra-hippocampal areas involved in the regulation of lo-
comotor activity, like midbrain dopamine nuclei and
their forebrain projection fields (Halim and Swerdlow
2000). The effects of ventral hippocampal infusions
might be mediated by the meso-accumbens dopamine
system, which can be influenced by the ventral hippo-
campus via direct projections to the nucleus accumbens
(Groenewegen et al. 1987) or via a loop including pro-
jections from the ventral hippocampus to the prefrontal
cortex (Verwer et al. 1997; see Legault et al. 2000). For
example, the hyperactivity induced by NMDA stimula-
tion of the ventral hippocampus seems to be due to in-
creased dopamine transmission in the nucleus accumb-
ens (Wu and Brudzynski 1995; Brudzynski and Gibson
1997; Bardgett and Henry 1999; Legault and Wise
1999; Bast et al. 2001b).
Decreased startle reactivity and disruption 
of prepulse inhibition following picrotoxin infusion 
into the ventral hippocampus
While infusion of both 100 and 150 ng picrotoxin/side
into the ventral hippocampus decreased the startle reac-
tivity to a similar extent, only the higher dose decreased
PPI. This is in line with several findings demonstrating
that the startle reflex and PPI can be modulated indepen-
dently and, specifically, that alterations of the startle am-
plitude do not necessarily result in changes of PPI (e.g.
Caine et al. 1992; Wan et al. 1996; Bast et al. 2000;
Zhang et al. 2000). Nevertheless, changes in startle reac-
tivity may in some instances result in decreased PPI.
Consequently, decreased PPI cannot unequivocally be
ascribed to impaired sensorimotor gating when it is par-
alleled by changes of the startle amplitude throughout
the pulse alone trials (for a detailed discussion see
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Swerdlow et al. 2000a). In the present study, %PPI was
reduced only by the higher dose of picrotoxin, whereas
both doses led to a similar decrease in startle reactivity,
indicating that this decrease cannot account for the PPI
deficit. Moreover, the comparison of the startle ampli-
tude in the different trial types demonstrated that the
higher dose of picrotoxin specifically impaired the pre-
pulses’ potency to reduce the startle amplitude in pre-
pulse followed by pulse trials. Thus, the decreased PPI
following infusion of 150 ng picrotoxin/side into the
ventral hippocampus appears to reflect a genuine impair-
ment of sensorimotor gating.
Decreased startle reactivity and disruption of PPI fol-
lowing disinhibition of the ventral hippocampus by pi-
crotoxin resemble the effects of ventral hippocampal
stimulation by infusion of excitatory substances, like
NMDA (Wan et al. 1996; Klarner et al. 1998; Koch et al.
1999; Zhang et al. 1999; Bast et al. 2001b) and the ace-
tylcholine agonist carbachol (Caine et al. 1992). Thus,
overactivity of the ventral hippocampus might be a criti-
cal factor to induce these effects. In contrast, ventral hip-
pocampal lesions did not alter basal PPI (Pouzet et al.
1999), but enhanced sensitivity to PPI disruption by the
dopamine agonist apomorphine (Swerdlow et al. 1995,
2000b), and one study reported increased startle reactivi-
ty following ventral hippocampal lesions (Swerdlow et
al. 1995). Moreover, though the non-competitive NMDA
antagonist MK-801 disrupts PPI very potently when ad-
ministered systemically, ventral hippocampal MK-801
infusions did not affect PPI (Bakshi and Geyer 1998;
Bast et al. 2001b). However, in view of our own results
indicating decreased startle reactivity and disrupted PPI
following tetrodotoxin or muscimol infusion into the
ventral hippocampus (T. Bast, W.-N. Zhang, J. Feldon,
unpublished observations), one has to consider that not
only overactivity but also other alterations of activity of
the ventral hippocampus may affect startle reactivity and
PPI.
The PPI disruption following NMDA stimulation of
the ventral hippocampus seems to be dopamine-indepen-
dent (Wan et al. 1996; Zhang et al. 1999; Bast et al.
2001b) and might be mediated by non-dopaminergic pro-
cesses in the prefrontal cortex, the nucleus accumbens,
or in the amygdala, all of which receive projections from
the ventral hippocampus (Groenwegen et al. 1987; 
Verwer et al. 1997; Pitkänen et al. 2000; see Bast et al.
2001b). The same might hold for the PPI disruption fol-
lowing disinhibition of the ventral hippocampus by pi-
crotoxin. However, Japha and Koch (1999), based on the
fact that haloperidol seemed to antagonize a non-signifi-
cant PPI impairment after infusion of 10 ng picrotox-
in/side into the ventral hippocampus of Sprague-Dawley
rats, proposed the opposite. Testing the effects of halo-
peridol pretreatment on the PPI disruption induced by in-
fusion of 150 ng picrotoxin/side into the ventral hippo-
campus of our Wistar rats could clarify this issue. The
circuits mediating the decrease of startle reactivity fol-
lowing stimulation or disinhibition of the ventral hippo-
campus might involve projections from the ventral hip-
pocampus to the amygdala or the bed nucleus of the stria
terminalis (Swanson and Cowan 1977; Pitkänen et al.
2000), which have access to the brain stem startle circuit
(Koch 1999).
Only the higher dose of picrotoxin disrupted PPI,
whereas both doses decreased the startle reactivity mark-
edly and to a similar extent. In contrast, infusions of
NMDA doses which potently disrupted PPI were not al-
ways found to decrease startle reactivity (Wan et al.
1996; Klarner et al. 1998; Koch et al. 1999; Zhang et al.
1999; Bast et al. 2001b; W.-N. Zhang, T. Bast, J. Feldon,
unpublished observations). Thus, disinhibition of the
ventral hippocampus by picrotoxin has a stronger impact
on the startle reactivity, whereas NMDA stimulation
more strongly affects PPI. This indicates slight differ-
ences in the neuronal processes induced by these two
forms of ventral hippocampal activation.
As a protective reaction to an aversive stimulus, the
startle response is enhanced by aversive states, such as
anxiety and fear, in rats as well as humans, and enhanced
startle reactivity is a diagnostic criterion of human anxi-
ety disorders (Lang 1995; Rodgers 1997; Filion et al.
1998; Koch 1999). Anxiety-related states, i.e. enhanced
behavioral reactivity to aversive stimuli, have been asso-
ciated with activity in the septo-hippocampal system
(Gray 1995) and particularly with decreased GABAA re-
ceptor-mediated inhibition in the hippocampus (see 
Crestani et al. 1999; Löw et al. 2000). The markedly de-
creased startle reactivity following infusion of the
GABAA antagonist picrotoxin into the ventral hippocam-
pus does not support these concepts.
Previous work has indicated that motor activity may
decrease startle reactivity and also PPI (Wecker and Ison
1986; Plappert et al. 1993). Whereas in particular groom-
ing had a strong effect, gross postural changes, such as
turning, did not affect startle and PPI (Wecker and Ison
1986). Picrotoxin infusion into the ventral hippocampus
induced increased locomotor activity, which results from
gross postural changes, while there was no evidence of
increased grooming. Thus, the hyperactivity induced by
the picrotoxin infusion into the ventral hippocampus
cannot account for the decreased startle reactivity and
PPI observed in the present study.
Conclusion
Blockade of GABAA receptors in the ventral hippocam-
pus induced hyperactivity in the open field and an im-
pairment of sensorimotor gating. These effects are simi-
lar to those induced by direct excitation of the ventral
hippocampus and related to psychotic symptoms. A con-
currence of increased afferent excitation and decreased
GABAergic inhibition might contribute to the hippocam-
pal overactivity in schizophrenic patients (Benes 2000).
In order to clarify the relevance of these aberrations with
respect to schizophrenic symptoms, it is of interest to ex-
amine whether excitation or disinhibition of the ventral
hippocampus in rats elicits further psychosis-related be-
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havioral disturbances, such as disruption of latent inhibi-
tion and other attentional processes (Gray et al. 1991;
Feldon and Weiner 1992). Interestingly, unpublished ob-
servations (B. Pouzet, W.-N. Zhang, and J. Feldon) indi-
cate that NMDA stimulation, in contrast to cytotoxic le-
sions, of the ventral hippocampus disrupts latent inhibi-
tion. Moreover, the effects of picrotoxin in the dorsal
hippocampus remain to be explored. Recent experi-
ments, however, demonstrating NMDA stimulation of
the dorsal hippocampus to hardly affect PPI and locomo-
tor activity (W.-N. Zhang, T. Bast, J. Feldon, unpub-
lished observations), indicate that these processes might
be much less affected by dorsal than by ventral hippo-
campal disinhibition.
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